Dan Grossman
Direttore/Membro del Consiglio presso Lyric Opera of Chicago
Profilo
Dan Grossman is currently a Director at Lyric Opera of Chicago and a Managing Director & Senior Partner at The Boston Consulting Group.
He also recently started a new job as a Director at Lykos Therapeutics, Inc. Dr. Grossman holds a doctorate degree from Princeton University and an undergraduate degree from Harvard College.
Posizioni attive di Dan Grossman
Società | Posizione | Inizio |
---|---|---|
Lyric Opera of Chicago
Lyric Opera of Chicago Movies/EntertainmentConsumer Services Lyric Opera of Chicago provides live theatrical presentations. The company was founded by Carol Fox, Nicola Rescigno and Lawrence V. Kelly in 1954 and is headquartered in Chicago, IL. | Direttore/Membro del Consiglio | - |
Lykos Therapeutics PBC
Lykos Therapeutics PBC BiotechnologyHealth Technology Part of Multidisciplinary Association for Psychedelic Studies, Lykos Therapeutics, Inc. is a public benefit corporation that focuses on developing and commercializing prescription psychedelics to provide better treatments for people with mental health conditions. The private company is based in San Jose, CA. Lykos Therapeutics aims to catalyze healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics, prioritizing public benefit above profit. The company was founded in 2014, and the CEO is Amy Emerson. | Direttore/Membro del Consiglio | 07/06/2022 |
The Boston Consulting Group | Corporate Officer/Principal | - |
Formazione di Dan Grossman
Princeton University | Doctorate Degree |
Harvard College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Lyric Opera of Chicago
Lyric Opera of Chicago Movies/EntertainmentConsumer Services Lyric Opera of Chicago provides live theatrical presentations. The company was founded by Carol Fox, Nicola Rescigno and Lawrence V. Kelly in 1954 and is headquartered in Chicago, IL. | Consumer Services |
The Boston Consulting Group | |
Lykos Therapeutics PBC
Lykos Therapeutics PBC BiotechnologyHealth Technology Part of Multidisciplinary Association for Psychedelic Studies, Lykos Therapeutics, Inc. is a public benefit corporation that focuses on developing and commercializing prescription psychedelics to provide better treatments for people with mental health conditions. The private company is based in San Jose, CA. Lykos Therapeutics aims to catalyze healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics, prioritizing public benefit above profit. The company was founded in 2014, and the CEO is Amy Emerson. | Health Technology |
- Borsa valori
- Insiders
- Dan Grossman